David Mahoney

Insider profile

Currently holds positions in Corcept Therapeutics Incorporated and Adamas Pharmaceuticals Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Corcept Therapeutics Incorporated July 26, 2004 -
Lead Independent Chairman of the Board Adamas Pharmaceuticals Inc Sept. 11, 2019 -
Independent Director Gen Digital Inc. April 10, 2003 - Dec. 19, 2019
Lead Independent Director Adamas Pharmaceuticals Inc Jan. 1, 2009 - Sept. 11, 2019
David Mahoney's trades of Corcept Therapeutics Incorporated's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-18
PlS Planned sale
20,174 +46.1%
82.20
US$3,666,903 		20,174 +46.1% 82.20 US$3,666,903
2026-08-20 2026-08-18
PlS Planned sale
16,947 +4.1%
19.56
US$825,172 		16,947 +4.1% 19.56 US$825,172
2026-08-20 2026-08-18
PlS Planned sale
72,003 +25.9%
448.16
US$3,773,704 		72,003 +25.9% 448.16 US$3,773,704
2026-08-20 2026-08-18
PlS Planned sale
4,984 -0.4%
117.47
US$585,478 		4,984 -0.4% 117.47 US$585,478
2026-08-18 2026-08-18
PrS Proposed sale
103,606
117.37
US$12,160,257 		103,606 117.37 US$12,160,257
2026-06-18 2026-06-17
S Sale
20,000 -43.3%
84.53
US$1,690,506 		20,000 -43.3% 84.53 US$1,690,506
2026-06-16 2026-06-16
PrS Proposed sale
20,000
83.34
US$1,666,800 		20,000 83.34 US$1,666,800
2025-05-20 2025-05-16
S Sale
3,523 -100.0%
74.65
US$263,001 		3,523 -100.0% 74.65 US$263,001
2025-05-20 2025-05-16
S Sale
23,829 -87.1%
74.17
US$1,767,452 		23,829 -87.1% 74.17 US$1,767,452
2025-05-16 2025-05-16
PrS Proposed sale
27,352
74.23
US$2,030,454 		27,352 74.23 US$2,030,454
2023-08-16 2023-08-14
S Sale
15,000 -1.2%
30.95
US$464,200 		15,000 -1.2% 30.95 US$464,200
2023-08-16 2023-08-14
S Sale
10,000 -47.0%
30.95
US$309,467 		10,000 -47.0% 30.95 US$309,467
2023-08-15 2023-08-14
PrS Proposed sale
10,000
30.87
US$308,700 		10,000 30.87 US$308,700
2023-08-14 2023-08-14
PrS Proposed sale
10,000
30.87
US$308,700 		10,000 30.87 US$308,700